Pharmacokinetics and tolerability of single escalating doses of cefetamet sodium in healthy volunteers.

Trial Profile

Pharmacokinetics and tolerability of single escalating doses of cefetamet sodium in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Mar 2013

At a glance

  • Drugs Cefetamet (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 21 Mar 2013 New trial record
    • 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top